Grupo-Publicaciones-GIIS069

Girón-Ortega J, Fernández-Guerrero R, de Oca Arjona M, Galán-Sanchez F, Pellejero Sagastizábal G, Morte Romea E, de Cueto M, Garcia M, Palacios-Baena Z, Jorge S, Rodríguez-Baño J, Retamar-Gentil P, NO-BACT Team . Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: A prospective multicentre cohort (NO-BACT).. JOURNAL OF INFECTION. 2024. 10.1016/j.jinf.2023.11.013. FI-14,3

Avendano-Sola C, Ramos-Martinez A, Munez-Rubio E, Ruiz-Antoran B, Malo de Molina R, Torres F, Fernandez-Cruz A, Calderon-Parra J, Payares-Herrera C, Diaz de Santiago A, Romera-Martinez I, Pintos I, Lora-Tamayo J, Mancheno-Losa M, Paciello M, Martinez-Gonzalez A, Vidan-Estevez J, Nunez-Orantos M, Isabel Saez-Serrano M, Porras-Leal M, Jarilla-Fernandez M, Villares P, Perez de Oteyza J, Ramos-Garrido A, Blanco L, Madrigal-Sanchez M, Rubio-Batlles M, Velasco-Iglesias A, Paño Pardo J, Moreno Chulilla J, Muniz-Diaz E, Casas-Flecha I, Perez-Olmeda M, Garcia-Perez J, Alcami J, Bueno J, Duarte R, ConPlas-19 Study Grp . A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. JOURNAL OF CLINICAL INVESTIGATION. 2021. 10.1172/JCI152740. FI-13,3

Uranga Murillo I, Morte Romea E, Hidalgo Arizón S, Pesini Martín C, García-Mulero S, Sierra J, Santiago García L, Arias Cabrero M, de Miguel Samaniego D, Encabo Berzosa M, Gracia Tello B, Sanz-Pamplona R, Martínez Lostao L, Galvez E, Paño Pardo J, Ramírez Labrada A, Pardo Jimeno J. Integrated analysis of circulating immune cellular and soluble mediators reveals  specific COVID19 signatures at hospital admission with utility for prediction of  clinical outcomes.. Theranostics. 2022. 10.7150/thno.63463. FI-12,4

Garzon-Tituana M, Sierra Monzón J, Comas Calmet L, Santiago García L, Khaliulina T, Uranga Murillo I, Ramírez Labrada A, Tapia E, Morte Romea E, Algarate Cajo S, Couty L, Camerer E, Bird P, Seral García C, Luque Gómez P, Paño Pardo J, Gálvez Buerba E, Pardo Jimeno J, Arias Cabrero M. Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis. Theranostics. 2021. 10.7150/thno.49288. FI-12,4

Yonga P, Pulcini C, Skov R, Paño Pardo J, Schouten J. The case for the access, watch, and reserve (AWaRe) universal guidelines for antibiotic use.. CLINICAL MICROBIOLOGY AND INFECTION. 2024. 10.1016/j.cmi.2024.04.003. FI-10,9

Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Martin-Quiros A, Paño Pardo J, Power N, Sibani M, Szabo B, Tsiodras S, Zollner-Schwetz I, Rodríguez-Baño J. European society of clinical microbiology and infectious diseases guidelines for  coronavirus disease 2019: an update on treatment of patients with mild/moderate  disease.. CLINICAL MICROBIOLOGY AND INFECTION. 2022. 10.1016/j.cmi.2022.08.013. FI-10,9

Barac A, Bartoletti M, Azap O, Bussini L, Ergonul O, Krause R, Paño Pardo J, Power N, Rodríguez-Baño J, Sibani M, Szabo B, Tsiodras S, Verweij P, Quirós A, Zollner-Schwetz I. Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!. CLINICAL MICROBIOLOGY AND INFECTION. 2022. 10.1016/j.cmi.2022.03.022. FI-10,9

Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Paño Pardo J, Power N, Sibani M, Szabo B, Tsiodras S, Verweij P, Zollner-Schwetz I, Rodríguez-Baño J. ESCMID COVID-19 living guidelines: drug treatment and clinical management.. CLINICAL MICROBIOLOGY AND INFECTION. 2022. 10.1016/j.cmi.2021.11.007. FI-10,9

Huttner B, Catho G, Paño Pardo J, Pulcini C, Schouten J. COVID-19: don’t neglect antimicrobial stewardship principles!. CLINICAL MICROBIOLOGY AND INFECTION. 2020. 10.1016/j.cmi.2020.04.024. FI-10,9

Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Martín-Quirós A, Paño Pardo J, Power N, Sibani M, Szabo B, Tsiodras S, Zollner-Schwetz I, Rodriguez-Baño J, ESCMID COVID-19 Treatment Guidelines Panel . ESCMID COVID-19 living guidelines: drug treatment and clinical management:  author’s reply.. CLINICAL MICROBIOLOGY AND INFECTION. 2022. 10.1016/j.cmi.2021.12.025. FI-10,9